Skip to content

Effect Of Trimada In The Management Of Uncontrolled Hypothyroidism

A Clinical Study Of Trimada As Adjuvant In The Management Of Uncontrolled Hypothyroidism

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/012049
Enrollment
30
Registered
2018-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patient suffering from uncontrolled hypothrodism

Interventions

Intervention1: A Clinical Study Of Trimada As Adjuvant In The Management Of Uncontrolled Hypothyroidism: 15 patients will be taken in group A and will be treated with TRIMADA churna in following dose

Sponsors

Government Akhandanand Ayurved College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Total Serum T4 level less than normal value and Thyroid stimulating hormone (TSH) level >4.25 μIU/mL and Patients who are already taking Levothyroxine however their Serum TSH Total Serum T3 T4 any one of them uncontrolled.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Result will be assessed on the basis of relief in the Signs and symptoms of UNCONTROLLED HYPOTHYROIDISM and normal Thyroid profileTimepoint: 4 weeks

Secondary

MeasureTime frame
Result will be assessed on the basis of relief in the Signs and symptoms of UNCONTROLLED HYPOTHYROIDISM and normal Thyroid profileTimepoint: 4 weeks

Countries

India

Contacts

Public ContactDigvesh Sitarambhai Bhoye

Kayachikitsa Department

dhanvantari4386@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026